|
|
Volumn 16, Issue 3, 2015, Pages 276-279
|
|
The second coming of epigenetic drugs: A more strategic and broader research framework could boost the development of new drugs to modify epigenetic factors and gene expression
a
a
NONE
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HISTONE;
NEW DRUG;
ARTICLE;
CANCER CELL;
CELL POPULATION;
CELL TRANSFORMATION;
CHROMATIN STRUCTURE;
COLON CANCER;
DEACETYLATION;
DNA HELIX;
DNA METHYLATION;
DNA TRANSCRIPTION;
EPIGENETICS;
GENE EXPRESSION;
GENE SILENCING;
HISTONE ACETYLATION;
HISTONE METHYLATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
PRIORITY JOURNAL;
RNA INTERFERENCE;
DRUG EFFECTS;
GENE EXPRESSION REGULATION;
GENETIC EPIGENESIS;
MEDICAL RESEARCH;
METABOLISM;
PHARMACOLOGY;
PROCEDURES;
TRENDS;
BIOMEDICAL RESEARCH;
DNA METHYLATION;
DRUGS, INVESTIGATIONAL;
EPIGENESIS, GENETIC;
GENE EXPRESSION REGULATION;
HISTONES;
HUMANS;
PHARMACOLOGY;
|
|
EID: 84924008674
PISSN: 1469221X
EISSN: 14693178
Source Type: Journal
DOI: 10.15252/embr.201540121 Document Type: Article |
|
Times cited : (17)
|
|
References (6)
|
